Tokyo Tape
Sign in
← Waqoo

Annual report

4937.TEDINET S100XCAJ
Period2024-10-01 → 2025-09-30
Filed2025-12-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 132
MetricValuePeriodScopeSource row
Revenue¥2.0bn2024-10-01 → 2025-09-30Cons.Net sales
Revenue¥1.9bn2023-10-01 → 2024-09-30Cons.Net sales
Revenue¥1.7bn2022-10-01 → 2023-09-30vCons.Net sales (5-year summary)
Revenue¥2.7bn2021-10-01 → 2022-09-30vCons.Net sales (5-year summary)
Operating income¥151m2024-10-01 → 2025-09-30Cons.Operating income
Operating income¥56m2023-10-01 → 2024-09-30Cons.Operating income
Ordinary income¥152m2024-10-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥57m2023-10-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥288m2022-10-01 → 2023-09-30vCons.Ordinary income loss (5-year summary)
Ordinary income−¥22m2021-10-01 → 2022-09-30vCons.Ordinary income loss (5-year summary)
Profit before tax¥152m2024-10-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥57m2023-10-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥44m2024-10-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥17m2023-10-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥28m2022-10-01 → 2023-09-30vCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥57m2021-10-01 → 2022-09-30vCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥44m2024-10-01 → 2025-09-30Cons.Profit loss
Net income−¥17m2023-10-01 → 2024-09-30Cons.Profit loss
Total assets¥3.2bnat 2025-09-30Cons.Assets
Total assets¥3.1bnat 2024-09-30Cons.Assets
Total assets¥1.6bnat 2023-09-30vCons.Total assets (5-year summary)
Total assets¥1.6bnat 2022-09-30vCons.Total assets (5-year summary)
Total liabilities¥1.1bnat 2025-09-30Cons.Liabilities
Total liabilities¥993mat 2024-09-30Cons.Liabilities
Net assets / equity¥2.1bnat 2025-09-30Cons.Net assets
Net assets / equity¥2.1bnat 2024-09-30Cons.Net assets
Net assets / equity¥773mat 2023-09-30vCons.Net assets
Net assets / equity¥743mat 2022-09-30vCons.Net assets (5-year summary)
Cash and deposits¥1.3bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥1.5bnat 2024-09-30Cons.Cash and deposits
Cash & equivalents¥1.3bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.5bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.3bnat 2023-09-30vCons.Cash and cash equivalents
Cash & equivalents¥906mat 2022-09-30vCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥136m2024-10-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥49m2023-10-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥456m2022-10-01 → 2023-09-30vCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥169m2021-10-01 → 2022-09-30vCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥189m2024-10-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥76m2023-10-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥49m2022-10-01 → 2023-09-30vCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥176m2021-10-01 → 2022-09-30vCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥150m2024-10-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥112m2023-10-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥8m2022-10-01 → 2023-09-30vCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥129m2021-10-01 → 2022-09-30vCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥12.322024-10-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-5.032023-10-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥9.432022-10-01 → 2023-09-30vCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-19.042021-10-01 → 2022-09-30vCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥12.242024-10-01 → 2025-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥9.322022-10-01 → 2023-09-30vCons.Diluted earnings per share (5-year summary)
Net assets per share¥591.15at 2025-09-30Cons.Net assets per share (5-year summary)
Net assets per share¥590.33at 2024-09-30Cons.Net assets per share (5-year summary)
Net assets per share¥256.73at 2023-09-30vCons.Net assets per share (5-year summary)
Net assets per share¥246.98at 2022-09-30vCons.Net assets per share (5-year summary)
Equity ratio65.1%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio68.2%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio48.9%at 2023-09-30vCons.Equity to asset ratio (5-year summary)
Equity ratio47.5%at 2022-09-30vCons.Equity to asset ratio (5-year summary)
ROE2.1%2024-10-01 → 2025-09-30Cons.Rate of return on equity (5-year summary)
ROE3.7%2022-10-01 → 2023-09-30vCons.Rate of return on equity (5-year summary)
Employees93at 2025-09-30Cons.Number of employees
Employees86at 2024-09-30Cons.Number of employees
Employees50at 2023-09-30vCons.Number of employees
Employees44at 2022-09-30vCons.Number of employees
Revenue¥1.3bn2024-10-01 → 2025-09-30StandaloneNet sales
Revenue¥1.6bn2023-10-01 → 2024-09-30StandaloneNet sales
Revenue¥1.7bn2022-10-01 → 2023-09-30vStandaloneNet sales (5-year summary)
Revenue¥2.7bn2021-10-01 → 2022-09-30vStandaloneNet sales (5-year summary)
Revenue¥4.7bn2020-10-01 → 2021-09-30dStandaloneNet sales (5-year summary)
Operating income−¥76m2024-10-01 → 2025-09-30StandaloneOperating income
Operating income−¥54m2023-10-01 → 2024-09-30StandaloneOperating income
Ordinary income−¥43m2024-10-01 → 2025-09-30StandaloneOrdinary income
Ordinary income−¥28m2023-10-01 → 2024-09-30StandaloneOrdinary income
Ordinary income¥275m2022-10-01 → 2023-09-30vStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥21m2021-10-01 → 2022-09-30vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥141m2020-10-01 → 2021-09-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥43m2024-10-01 → 2025-09-30StandaloneIncome before income taxes
Profit before tax−¥28m2023-10-01 → 2024-09-30StandaloneIncome before income taxes
Net income−¥45m2024-10-01 → 2025-09-30StandaloneProfit loss
Net income−¥30m2023-10-01 → 2024-09-30StandaloneProfit loss
Net income¥32m2022-10-01 → 2023-09-30vStandaloneNet income loss (5-year summary)
Net income−¥57m2021-10-01 → 2022-09-30vStandaloneNet income loss (5-year summary)
Net income¥116m2020-10-01 → 2021-09-30dStandaloneNet income loss (5-year summary)
Total assets¥2.7bnat 2025-09-30StandaloneAssets
Total assets¥2.9bnat 2024-09-30StandaloneAssets
Total assets¥1.6bnat 2023-09-30vStandaloneTotal assets (5-year summary)
Total assets¥1.6bnat 2022-09-30vStandaloneTotal assets (5-year summary)
Total assets¥1.9bnat 2021-09-30dStandaloneTotal assets (5-year summary)
Total liabilities¥711mat 2025-09-30StandaloneLiabilities
Total liabilities¥810mat 2024-09-30StandaloneLiabilities
Net assets / equity¥2.0bnat 2025-09-30StandaloneNet assets
Net assets / equity¥2.1bnat 2024-09-30StandaloneNet assets
Net assets / equity¥777mat 2023-09-30vStandaloneNet assets
Net assets / equity¥743mat 2022-09-30vStandaloneNet assets (5-year summary)
Net assets / equity¥801mat 2021-09-30dStandaloneNet assets (5-year summary)
Cash and deposits¥976mat 2025-09-30StandaloneCash and deposits
Cash and deposits¥1.2bnat 2024-09-30StandaloneCash and deposits
Cash & equivalents¥1.0bnat 2021-09-30dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥128m2020-10-01 → 2021-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥6m2020-10-01 → 2021-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥703m2020-10-01 → 2021-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-12.562024-10-01 → 2025-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-8.772023-10-01 → 2024-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥10.572022-10-01 → 2023-09-30vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-18.952021-10-01 → 2022-09-30vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥41.612020-10-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥10.442022-10-01 → 2023-09-30vStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥40.92020-10-01 → 2021-09-30dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥563.24at 2025-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥587.77at 2024-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥257.96at 2023-09-30vStandaloneNet assets per share (5-year summary)
Net assets per share¥247.07at 2022-09-30vStandaloneNet assets per share (5-year summary)
Net assets per share¥266.72at 2021-09-30dStandaloneNet assets per share (5-year summary)
Equity ratio73.4%at 2025-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio72.3%at 2024-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio49.2%at 2023-09-30vStandaloneEquity to asset ratio (5-year summary)
Equity ratio47.5%at 2022-09-30vStandaloneEquity to asset ratio (5-year summary)
Equity ratio42.1%at 2021-09-30dStandaloneEquity to asset ratio (5-year summary)
ROE4.2%2022-10-01 → 2023-09-30vStandaloneRate of return on equity (5-year summary)
ROE24.1%2020-10-01 → 2021-09-30dStandaloneRate of return on equity (5-year summary)
Shares issued3,622,668at 2025-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued3,618,928at 2024-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued3,010,278at 2023-09-30vStandaloneTotal number of issued shares (5-year summary)
Shares issued3,006,178at 2022-09-30vStandaloneTotal number of issued shares (5-year summary)
Shares issued3,001,178at 2021-09-30dStandaloneTotal number of issued shares (5-year summary)
Employees61at 2025-09-30StandaloneNumber of employees
Employees60at 2024-09-30StandaloneNumber of employees
Employees50at 2023-09-30vStandaloneNumber of employees
Employees44at 2022-09-30vStandaloneNumber of employees
Employees72at 2021-09-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 48
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2024-10-01 → 2025-09-30¥5m
Reconciling Itemsreconcilingdepreciation2024-10-01 → 2025-09-30¥682,000
Reconciling Itemsreconcilingrevenue2024-10-01 → 2025-09-30¥9m
Reconciling Itemsreconcilingrevenue external2024-10-01 → 2025-09-30¥9m
Reconciling Itemsreconcilingsegment profit2024-10-01 → 2025-09-30−¥28m
Direct To Consumer Businessreportable segmentrevenue2024-10-01 → 2025-09-30¥953m
Direct To Consumer Businessreportable segmentrevenue external2024-10-01 → 2025-09-30¥953m
Direct To Consumer Businessreportable segmentsegment profit2024-10-01 → 2025-09-30¥295m
Medical Supportreportable segmentrevenue2024-10-01 → 2025-09-30¥1.0bn
Medical Supportreportable segmentrevenue external2024-10-01 → 2025-09-30¥999m
Medical Supportreportable segmentrevenue intersegment2024-10-01 → 2025-09-30¥1m
Medical Supportreportable segmentsegment profit2024-10-01 → 2025-09-30¥216m
—segment totalcapex2024-10-01 → 2025-09-30¥262m
—segment totaldepreciation2024-10-01 → 2025-09-30¥13m
—segment totalrevenue2024-10-01 → 2025-09-30¥2.0bn
—segment totalrevenue external2024-10-01 → 2025-09-30¥2.0bn
—segment totalrevenue intersegment2024-10-01 → 2025-09-30¥1m
—segment totalsegment profit2024-10-01 → 2025-09-30¥511m
Total Of Reportable Segments And Otherssegment totalcapex2024-10-01 → 2025-09-30¥262m
Total Of Reportable Segments And Otherssegment totaldepreciation2024-10-01 → 2025-09-30¥13m
Reconciling Itemsreconcilingcapex2023-10-01 → 2024-09-30¥322,000
Reconciling Itemsreconcilingdepreciation2023-10-01 → 2024-09-30¥745,000
Reconciling Itemsreconcilingrevenue2023-10-01 → 2024-09-30−¥2m
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2024-09-30−¥2m
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-09-30−¥393m
Direct To Consumer Businessreportable segmentdepreciation2023-10-01 → 2024-09-30¥5m
Direct To Consumer Businessreportable segmentrevenue2023-10-01 → 2024-09-30¥1.3bn
Direct To Consumer Businessreportable segmentrevenue external2023-10-01 → 2024-09-30¥1.3bn
Direct To Consumer Businessreportable segmentrevenue intersegment2023-10-01 → 2024-09-30¥75,000
Direct To Consumer Businessreportable segmentsegment profit2023-10-01 → 2024-09-30¥386m
Medical Supportreportable segmentcapex2023-10-01 → 2024-09-30¥80m
Medical Supportreportable segmentdepreciation2023-10-01 → 2024-09-30¥8m
Medical Supportreportable segmentrevenue2023-10-01 → 2024-09-30¥629m
Medical Supportreportable segmentrevenue external2023-10-01 → 2024-09-30¥627m
Medical Supportreportable segmentrevenue intersegment2023-10-01 → 2024-09-30¥2m
Medical Supportreportable segmentsegment profit2023-10-01 → 2024-09-30¥64m
—segment totalcapex2023-10-01 → 2024-09-30¥80m
—segment totaldepreciation2023-10-01 → 2024-09-30¥12m
—segment totalrevenue2023-10-01 → 2024-09-30¥1.9bn
—segment totalrevenue external2023-10-01 → 2024-09-30¥1.9bn
—segment totalrevenue intersegment2023-10-01 → 2024-09-30¥2m
—segment totalsegment profit2023-10-01 → 2024-09-30¥450m
Total Of Reportable Segments And Otherssegment totalcapex2023-10-01 → 2024-09-30¥80m
Total Of Reportable Segments And Otherssegment totaldepreciation2023-10-01 → 2024-09-30¥12m
Total Of Reportable Segments And Otherssegment totalrevenue2023-10-01 → 2024-09-30¥1.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-10-01 → 2024-09-30¥1.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-10-01 → 2024-09-30¥2m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-10-01 → 2024-09-30¥450m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,221
ItemContextValueUnit
Net increase decrease in cash and cash equivalentsPrior1YearDuration85246000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration-203029000JPY
Cash and cash equivalentsPrior2YearInstant1305025000JPY
Cash and cash equivalentsPrior1YearInstant1505331000JPY
Increase in cash and cash equivalents resulting from share exchanges cfPrior1YearDuration115059000JPY
Increase in cash and cash equivalents resulting from share exchanges cfCurrentYearDuration－JPY
Cash and cash equivalentsPrior1YearInstant1505331000JPY
Cash and cash equivalentsCurrentYearInstant1302301000JPY
Number of consolidated subsidiariesCurrentYearInstant1
Cost of sales notes regarding write downs of inventoriesPrior1YearDuration-15979000JPY
Cost of sales notes regarding write downs of inventoriesCurrentYearDuration-446000JPY
Payrolls and allowances etc sgaPrior1YearDuration326894000JPY
Payrolls and allowances etc sgaCurrentYearDuration407714000JPY
Advertising expenses sgaPrior1YearDuration246989000JPY
Advertising expenses sgaCurrentYearDuration135222000JPY
Freightage and packing expenses sgaPrior1YearDuration181623000JPY
Freightage and packing expenses sgaCurrentYearDuration138568000JPY
Amortization of goodwill sgaPrior1YearDuration91787000JPY
Amortization of goodwill sgaCurrentYearDuration122383000JPY
Compensations sgaPrior1YearDuration214619000JPY
Compensations sgaCurrentYearDuration103705000JPY
Sales commission sgaPrior1YearDuration90905000JPY
Sales commission sgaCurrentYearDuration77419000JPY
Depreciation sgaPrior1YearDuration8157000JPY
Depreciation sgaCurrentYearDuration2379000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodPrior1YearDuration9169000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodCurrentYearDuration37675000JPY
Revenues from external customersPrior1YearDuration_jpcrp030000-asr_E36697-000DirectToConsumerBusinessReportableSegmentMember1316329000JPY
Revenues from external customersPrior1YearDuration_jpcrp030000-asr_E36697-000MedicalSupportReportableSegmentMember627074000JPY
Revenues from external customersPrior1YearDuration_ReportableSegmentsMember1943404000JPY
Revenues from external customersPrior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Revenues from external customersPrior1YearDuration_TotalOfReportableSegmentsAndOthersMember1943404000JPY
Revenues from external customersPrior1YearDuration1943404000JPY
Transactions with other segmentsPrior1YearDuration_jpcrp030000-asr_E36697-000DirectToConsumerBusinessReportableSegmentMember75000JPY
Transactions with other segmentsPrior1YearDuration_jpcrp030000-asr_E36697-000MedicalSupportReportableSegmentMember1597000JPY
Transactions with other segmentsPrior1YearDuration_ReportableSegmentsMember1673000JPY
Transactions with other segmentsPrior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Transactions with other segmentsPrior1YearDuration_TotalOfReportableSegmentsAndOthersMember1673000JPY
Transactions with other segmentsPrior1YearDuration_ReconcilingItemsMember-1673000JPY
Transactions with other segmentsPrior1YearDuration－JPY
Net salesPrior1YearDuration_jpcrp030000-asr_E36697-000DirectToConsumerBusinessReportableSegmentMember1316404000JPY
Net salesPrior1YearDuration_jpcrp030000-asr_E36697-000MedicalSupportReportableSegmentMember628672000JPY
Net salesPrior1YearDuration_ReportableSegmentsMember1945077000JPY
Net salesPrior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Net salesPrior1YearDuration_TotalOfReportableSegmentsAndOthersMember1945077000JPY
Net salesPrior1YearDuration_ReconcilingItemsMember-1673000JPY
Net salesPrior1YearDuration1943404000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E36697-000DirectToConsumerBusinessReportableSegmentMember385502000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E36697-000MedicalSupportReportableSegmentMember64001000JPY
Operating incomePrior1YearDuration_ReportableSegmentsMember449504000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2024-09-30pass
balance sheet identityconsolidated 2025-09-30pass
balance sheet identitynon_consolidated 2024-09-30pass
balance sheet identitynon_consolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · net assetsnon_consolidated 2024-09-30pass
statement vs summary · net assetsnon_consolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-10-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2024-10-01/2025-09-30pass
statement vs summary · revenueconsolidated 2023-10-01/2024-09-30pass
statement vs summary · revenueconsolidated 2024-10-01/2025-09-30pass
statement vs summary · revenuenon_consolidated 2023-10-01/2024-09-30pass
statement vs summary · revenuenon_consolidated 2024-10-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2024-09-30pass
statement vs summary · total assetsconsolidated 2025-09-30pass
statement vs summary · total assetsnon_consolidated 2024-09-30pass
statement vs summary · total assetsnon_consolidated 2025-09-30pass